• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Consumer Cyclical·3332.HK
Share

Nanjing Sinolife United Company Limited Stocks

HK$ 0.14Last Updated 31.07.2026

Issuer Rating

3/7
Performance

Favourable

Risk

High

Recommendation

Sell

Market Cap

HK$ 12.31M

HK$ 0.14
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Nanjing Sinolife United Company Limited functions as an investment holding entity primarily involved in the manufacturing, processing, and global distribution of nutritional supplements. Its operations span the People's Republic of China, Australia, New Zealand, Vietnam, and various international markets. The firm additionally produces and markets cosmetics and skincare items, while also undertaking the trading, retail, and testing of pre-packaged health food products. Products are sold under well-known brands such as Good Health, Zhongsheng, Hejian, and Cobayer, primarily via its comprehensive network of retail outlets. Distribution also encompasses sales through distributors, television shopping channels, online e-commerce platforms, chain pharmacies, specialized health food supermarkets, and tourist souvenir shops. The company, which has been headquartered in Nanjing, China, since its establishment in 1999.

Company Valuation

Greatly undervalued
7/7

Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers. In particular, the stock is underpriced on P/E, undervalued on P/F

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

31.07.2026 15:00

Apnimed IPO: A company backed by an investor in Uber, X, and Revolut has gone public

31.07.2026 14:44

Tesla May Sell Its China Business to Merge with SpaceX — WSJ. Musk Denies This

31.07.2026 14:28

Lessons for Wall Street: 6 Questions About Aschenbrenner, the “AI Nostradamus,” and the Collapse of His Fund

31.07.2026 14:00

A Focus on Kazakhstan, Copper, and Low Costs: Why Analysts Have Faith in Arras Minerals

31.07.2026 13:23

The New York District Attorney's Office has filed a lawsuit against the prediction platform Kalshi

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026